Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Whole-Genome Sequencing for National Surveillance of Shigella flexneri.

Chattaway MA, Greig DR, Gentle A, Hartman HB, Dallman TJ, Jenkins C.

Front Microbiol. 2017 Sep 19;8:1700. doi: 10.3389/fmicb.2017.01700. eCollection 2017.

2.

A Genome Scale Model of Geobacillus thermoglucosidasius (C56-YS93) reveals its biotechnological potential on rice straw hydrolysate.

Ahmad A, Hartman HB, Krishnakumar S, Fell DA, Poolman MG, Srivastava S.

J Biotechnol. 2017 Jun 10;251:30-37. doi: 10.1016/j.jbiotec.2017.03.031. Epub 2017 Apr 4.

PMID:
28385593
3.

Identification of potential drug targets in Salmonella enterica sv. Typhimurium using metabolic modelling and experimental validation.

Hartman HB, Fell DA, Rossell S, Jensen PR, Woodward MJ, Thorndahl L, Jelsbak L, Olsen JE, Raghunathan A, Daefler S, Poolman MG.

Microbiology. 2014 Jun;160(Pt 6):1252-1266. doi: 10.1099/mic.0.076091-0. Epub 2014 Apr 28.

PMID:
24777662
4.

Neural circuit recording from an intact cockroach nervous system.

Titlow JS, Majeed ZR, Hartman HB, Burns E, Cooper RL.

J Vis Exp. 2013 Nov 4;(81):e50584. doi: 10.3791/50584.

5.

Proprioception and tension receptors in crab limbs: student laboratory exercises.

Majeed ZR, Titlow J, Hartman HB, Cooper R.

J Vis Exp. 2013 Oct 24;(80):e51050. doi: 10.3791/51050.

6.

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.

Quinet EM, Basso MD, Halpern AR, Yates DW, Steffan RJ, Clerin V, Resmini C, Keith JC, Berrodin TJ, Feingold I, Zhong W, Hartman HB, Evans MJ, Gardell SJ, DiBlasio-Smith E, Mounts WM, LaVallie ER, Wrobel J, Nambi P, Vlasuk GP.

J Lipid Res. 2009 Dec;50(12):2358-70. doi: 10.1194/jlr.M900037-JLR200. Epub 2009 Mar 24.

7.

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice.

Hartman HB, Gardell SJ, Petucci CJ, Wang S, Krueger JA, Evans MJ.

J Lipid Res. 2009 Jun;50(6):1090-100. doi: 10.1194/jlr.M800619-JLR200. Epub 2009 Jan 27.

8.

Loss of small heterodimer partner expression in the liver protects against dyslipidemia.

Hartman HB, Lai K, Evans MJ.

J Lipid Res. 2009 Feb;50(2):193-203. doi: 10.1194/jlr.M800323-JLR200. Epub 2008 Sep 26.

9.

The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.

Wang S, Lai K, Moy FJ, Bhat A, Hartman HB, Evans MJ.

Endocrinology. 2006 Sep;147(9):4025-33. Epub 2006 May 4.

PMID:
16675527
10.
11.

Mechanisms regulating adipocyte expression of resistin.

Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA.

J Biol Chem. 2002 May 31;277(22):19754-61. Epub 2002 Mar 18.

12.
13.

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM.

J Pharmacol Exp Ther. 1997 Feb;280(2):710-20.

PMID:
9023283
14.
15.

Iloperidone binding to human and rat dopamine and 5-HT receptors.

Kongsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L, Sandrasagra A.

Eur J Pharmacol. 1996 Dec 19;317(2-3):417-23.

PMID:
8997630
16.

Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.

Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R.

J Med Chem. 1996 Sep 27;39(20):4044-57.

PMID:
8831770
17.

3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).

Strupczewski JT, Bordeau KJ, Chiang Y, Glamkowski EJ, Conway PG, Corbett R, Hartman HB, Szewczak MR, Wilmot CA, Helsley GC.

J Med Chem. 1995 Mar 31;38(7):1119-31.

PMID:
7707315
18.

Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents.

Hrib NJ, Jurcak JG, Burgher KL, Conway PG, Hartman HB, Kerman LL, Roehr JE, Woods AT.

J Med Chem. 1994 Jul 22;37(15):2308-14.

PMID:
7914536
19.
20.
21.

3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia.

Hrib NJ, Jurcak JG, Bregna DE, Dunn RW, Geyer HM 3rd, Hartman HB, Roehr JE, Rogers KL, Rush DK, Szczepanik AM, et al.

J Med Chem. 1992 Jul 10;35(14):2712-5. No abstract available.

PMID:
1353116
22.

Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinity.

Hubbard JW, Conway PG, Nordstrom LC, Hartman HB, Lebedinsky Y, O'Malley GJ, Kosley RW Jr.

J Pharmacol Exp Ther. 1991 Feb;256(2):621-7.

PMID:
1993999
23.

Receptors signaling gravity orientation in an insect.

Hartman HB.

Physiologist. 1979 Dec;22(6):S49-50. No abstract available.

PMID:
545385
24.

Giant interneurons mediating equilibrium reception in an insect.

Hartman HB, Walthall WW, Bennett LP, Stewart RR.

Science. 1979 Aug 3;205(4405):503-5.

PMID:
17758792
25.

Gene differences influencing visual system function and behavior.

Hegmann JP, Kieso RA, Hartman HB.

Behav Genet. 1974 Jun;4(2):165-70. No abstract available.

PMID:
4842093
26.

Stridulation by the cockroach Nauphoeta cinerea during courtship behaviour.

Hartman HB, Roth LM.

J Insect Physiol. 1967 Apr;13(4):579-86. No abstract available.

PMID:
6045150

Supplemental Content

Loading ...
Support Center